Mark Woodhams - Dec 12, 2024 Form 4 Insider Report for BLACKLINE, INC. (BL)

Role
Chief Revenue Officer
Signature
/s/ Karole Morgan-Prager, Attorney-in-Fact
Stock symbol
BL
Transactions as of
Dec 12, 2024
Transactions value $
-$1,005,254
Form type
4
Date filed
12/16/2024, 04:15 PM
Previous filing
Nov 21, 2024
Next filing
Dec 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BL Common Stock Options Exercise $392K +8K +9.32% $49.04 93.8K Dec 12, 2024 Direct F1
transaction BL Common Stock Options Exercise $172K +3.54K +3.78% $48.65 97.3K Dec 12, 2024 Direct F1
transaction BL Common Stock Sale -$1.36M -21.2K -21.83% $64.25 76.1K Dec 12, 2024 Direct F1, F2
transaction BL Common Stock Sale -$205K -3.17K -4.16% $64.78 72.9K Dec 12, 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BL Stock Option (Right to Buy) Options Exercise $0 -3.54K -10.45% $0.00 30.4K Dec 12, 2024 Common Stock 3.54K $48.65 Direct F1, F4
transaction BL Stock Option (Right to Buy) Options Exercise $0 -8K -8.98% $0.00 81.1K Dec 12, 2024 Common Stock 8K $49.04 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported on this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.
F2 The sale price represents the weighted average price of shares sold ranging from $63.74 to $64.73 per share, and is rounded to the nearest tenth of a cent. Upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 The sale price represents the weighted average price of shares sold ranging from $64.74 to $64.86 per share, and is rounded to the nearest tenth of a cent. Upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4 The options became exercisable based on the following vesting schedule, which shall be satisfied over a 5-year period: 25% of the shares subject to the option vested on the one (1) year anniversary of the grant date (the "Annual Option Vesting Commencement Date"), and 1/16th of the remaining options vest every three months thereafter on the same day of the month as the Annual Option Vesting Commencement Date, subject to the reporting person's continued service through each applicable vesting date.